Research on non-small cell lung cancer is providing insights into the evolution of metastases. Studies are characterizing the genomic divergence between primary and metastatic tumors, as well as the role of tumor heterogeneity in therapeutic resistance. The findings may help refine treatment strategies for non-small cell lung cancer, although the specifics of the research and its implications are still being explored.